Architectural Heterogeneity and Cribriform Pattern Predict Adverse Clinical Outcome for Gleason Grade 4 Prostatic Adenocarcinoma

被引:115
作者
Dong, Fei [1 ]
Yang, Ping [1 ,3 ]
Wang, Chaofu [1 ]
Wu, Shulin [1 ]
Xiao, Yu [1 ]
McDougal, W. Scott [2 ]
Young, Robert H. [1 ]
Wu, Chin-Lee [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA
[3] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China
关键词
prostate cancer; Gleason score; grade; prognosis; metastasis; 2005; INTERNATIONAL-SOCIETY; INTEROBSERVER REPRODUCIBILITY; RADICAL PROSTATECTOMY; NEEDLE-BIOPSY; CARCINOMA; CANCER; PROGRESSION;
D O I
10.1097/PAS.0b013e3182a02169
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Gleason grade 4 defines a group of prostatic adenocarcinomas with a variety of architectural patterns, including poorly formed glands, fused glands, and cribriform pattern. To address the relative contribution to clinical prognosis by these distinct patterns, the histology of 241 consecutive radical prostatectomy specimens with the highest Gleason grade of 4 was reviewed. The presence of poorly formed glands, fused glands, and cribriform pattern was recorded for each case, and the types of architectural patterns present were associated with patient outcome. In this population, prostatic adenocarcinomas demonstrated architectural heterogeneity, with 17% of cases exhibiting a single Gleason grade 4 pattern, and 41% of cases exhibiting all 3 morphologic patterns. Patients exhibiting all 3 architectural patterns had lower rates of biochemical disease-free survival (66% vs. 76% at 5 y; log rank P= 0.006). Twenty-two of 165 patients (13.3%) with cribriform pattern adenocarcinoma developed metastasis, whereas 2 of 76 patients (2.6%) without cribriform pattern developed metastasis at a median postoperative follow-up of 10.0 years. The presence of a cribriform pattern was an independent predictor for biochemical recurrence (hazard ratio 2.41; 95% confidence interval, 1.34-4.32; P = 0.003) as well as metastasis after radical prostatectomy (hazard ratio 5.62; 95% confidence interval, 1.29-24.5; P = 0.02). These results suggest that the morphologic sub-classification of distinct Gleason grade 4 architectural patterns provides prognostic information beyond the current Gleason classification system.
引用
收藏
页码:1855 / 1861
页数:7
相关论文
共 23 条
  • [1] Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists
    Allsbrook, WC
    Mangold, KA
    Johnson, MH
    Lane, RB
    Lane, CG
    Amin, MB
    Bostwick, DG
    Humphrey, PA
    Jones, EC
    Reuter, VE
    Sakr, W
    Sesterhenn, IA
    Troncoso, P
    Wheeler, TM
    Epstein, JI
    [J]. HUMAN PATHOLOGY, 2001, 32 (01) : 74 - 80
  • [2] Bailar J C 3rd, 1966, Cancer Chemother Rep, V50, P129
  • [3] Time trends in clinical risk stratification for prostate cancer: Implications for outcomes (data from CaPSURE)
    Cooperberg, MR
    Lubeck, DP
    Mehta, SS
    Carroll, PR
    [J]. JOURNAL OF UROLOGY, 2003, 170 (06) : S21 - S25
  • [4] Impact on the Clinical Outcome of Prostate Cancer by the 2005 International Society of Urological Pathology Modified Gleason Grading System
    Dong, Fei
    Wang, Chaofu
    Farris, A. Brad
    Wu, Shulin
    Lee, Hang
    Olumi, Aria F.
    McDougal, W. Scott
    Young, Robert H.
    Wu, Chin-Lee
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (06) : 838 - 843
  • [5] Edge S., 2010, AJCC Cancer Staging Manual, P457
  • [6] Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
    Eggener, Scott E.
    Scardino, Peter T.
    Walsh, Patrick C.
    Han, Misop
    Partin, Alan W.
    Trock, Bruce J.
    Feng, Zhaoyong
    Wood, David P.
    Eastham, James A.
    Yossepowitch, Ofer
    Rabah, Danny M.
    Kattan, Michael W.
    Yu, Changhong
    Klein, Eric A.
    Stephenson, Andrew J.
    [J]. JOURNAL OF UROLOGY, 2011, 185 (03) : 869 - 875
  • [7] The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
    Epstein, JI
    Allsbrook, WC
    Amin, MB
    Egevad, LL
    Bastacky, S
    Beltrán, AL
    Berner, A
    Billis, A
    Boccon-Gibod, L
    Cheng, L
    Civantos, F
    Cohen, C
    Cohen, MB
    Datta, M
    Davis, C
    Delahunt, B
    Delprado, W
    Eble, JN
    Foster, CS
    Furusato, M
    Gaudin, PB
    Grignon, DJ
    Humphrey, PA
    Iczkowski, KA
    Jones, EC
    Lucia, S
    McCue, PA
    Nazeer, T
    Oliva, E
    Pan, CC
    Pizov, G
    Reuter, V
    Samaratunga, H
    Sebo, T
    Sesterhenn, I
    Shevchuk, M
    Srigley, JR
    Suzigan, S
    Takahashi, H
    Tamboli, P
    Tan, PH
    Têtu, B
    Tickoo, S
    Tomaszewski, JE
    Troncoso, P
    Tsuzuki, T
    True, LD
    van der Kwast, T
    Wheeler, TM
    Wojno, KJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1228 - 1242
  • [8] EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO
  • [9] 2-Y
  • [10] Prediction of progression following radical prostatectomy - A multivariate analysis of 721 men with long-term follow-up
    Epstein, JI
    Partin, AW
    Sauvageot, J
    Walsh, PC
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (03) : 286 - 292